Approval · Notice of Compliance 12997 · 2012
AVA-FINASTERIDE: Notice of Compliance 12997
Issued February 2, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12997
- Date
- February 2, 2012
- Company
- Avanstra IncCalgary, Alberta, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Type II 5 Alpha-Reductase Inhibitor
- Canadian reference product
- PROSCAR (Merck Frosst Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AVA-FINASTERIDE | 02378515 | — |
Medicinal ingredients
- FINASTERIDE 5 MG per TAB